Recalcitrant allergic contact dermatitis from azathioprine tablets.
Lauerma
A I
AI
Skin and Allergy Hospital, Helsinki University Central Hospital, Finland.
Koivuluhta
M
M
Alenius
H
H
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects; D010328:Patch Tests; D011241:Prednisone / Q000627:therapeutic use; D013607:Tablets / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D013607:Tablets; D001379:Azathioprine; D011241:Prednisone